Résultats de recherche auteurs

1

Figure 4 from In Vivo Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma par Nicholas T. Younger (14956251)

Publié 2025
Autres auteurs:

Ajouter aux favoris

Enregistré dans:
2

Figure 1 from In Vivo Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma par Nicholas T. Younger (14956251)

Publié 2025
Autres auteurs:

Ajouter aux favoris

Enregistré dans:
3

Figure 2 from In Vivo Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma par Nicholas T. Younger (14956251)

Publié 2025
Autres auteurs:

Ajouter aux favoris

Enregistré dans:
4

Figure 3 from In Vivo Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma par Nicholas T. Younger (14956251)

Publié 2025
Autres auteurs:

Ajouter aux favoris

Enregistré dans:
5

Table 1 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification par Robert L. Hollis (15034814)

Publié 2025
Autres auteurs: “…Alison M. Meynert (14956260)…”

Ajouter aux favoris

Enregistré dans:
6

Figure 4 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification par Robert L. Hollis (15034814)

Publié 2025
Autres auteurs: “…Alison M. Meynert (14956260)…”

Ajouter aux favoris

Enregistré dans:
7

Figure 3 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification par Robert L. Hollis (15034814)

Publié 2025
Autres auteurs: “…Alison M. Meynert (14956260)…”

Ajouter aux favoris

Enregistré dans:
8

Figure 1 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification par Robert L. Hollis (15034814)

Publié 2025
Autres auteurs: “…Alison M. Meynert (14956260)…”

Ajouter aux favoris

Enregistré dans:
9

Figure 5 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification par Robert L. Hollis (15034814)

Publié 2025
Autres auteurs: “…Alison M. Meynert (14956260)…”

Ajouter aux favoris

Enregistré dans:
10

Figure 2 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification par Robert L. Hollis (15034814)

Publié 2025
Autres auteurs: “…Alison M. Meynert (14956260)…”

Ajouter aux favoris

Enregistré dans:

Figure 4 from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma par Nicholas T. Younger (14956251)

Figure 1 from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma par Nicholas T. Younger (14956251)

Figure 2 from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma par Nicholas T. Younger (14956251)

Figure 3 from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma par Nicholas T. Younger (14956251)

Table 1 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification par Robert L. Hollis (15034814)

Figure 4 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification par Robert L. Hollis (15034814)

Figure 3 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification par Robert L. Hollis (15034814)

Figure 1 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification par Robert L. Hollis (15034814)

Figure 5 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification par Robert L. Hollis (15034814)

Figure 2 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification par Robert L. Hollis (15034814)

Figure 4 from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma par Nicholas T. Younger (14956251)

Figure 1 from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma par Nicholas T. Younger (14956251)

Figure 2 from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma par Nicholas T. Younger (14956251)

Figure 3 from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma par Nicholas T. Younger (14956251)

Table 1 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification par Robert L. Hollis (15034814)

Figure 4 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification par Robert L. Hollis (15034814)

Figure 3 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification par Robert L. Hollis (15034814)

Figure 1 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification par Robert L. Hollis (15034814)

Figure 5 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification par Robert L. Hollis (15034814)

Figure 2 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification par Robert L. Hollis (15034814)

Outils de recherche: